Anna Kemp

1.5k total citations
58 papers, 1.1k citations indexed

About

Anna Kemp is a scholar working on Economics and Econometrics, General Health Professions and Cancer Research. According to data from OpenAlex, Anna Kemp has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Economics and Econometrics, 11 papers in General Health Professions and 7 papers in Cancer Research. Recurrent topics in Anna Kemp's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Healthcare Policy and Management (13 papers) and Pharmaceutical Economics and Policy (9 papers). Anna Kemp is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Healthcare Policy and Management (13 papers) and Pharmaceutical Economics and Policy (9 papers). Anna Kemp collaborates with scholars based in Australia, United States and Canada. Anna Kemp's co-authors include Elizabeth E. Roughead, David B. Preen, Nicole Pratt, John D. Barratt, Lisa Kalisch Ellett, Emmae Ramsay, Mhairi Kerr, J. Glover, James B. Semmens and Rosemary Korda and has published in prestigious journals such as PLoS ONE, Journal of the American Society of Nephrology and Computers in Human Behavior.

In The Last Decade

Anna Kemp

55 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Kemp Australia	18	223	217	166	154	123	58	1.1k
Virginia Wang United States	18	353 1.6×	474 2.2×	371 2.2×	214 1.4×	113 0.9×	89	1.2k
Hassan Fouayzi United States	20	188 0.8×	181 0.8×	360 2.2×	93 0.6×	138 1.1×	44	1.5k
Haitham Tuffaha Australia	18	235 1.1×	165 0.8×	39 0.2×	120 0.8×	64 0.5×	78	1.2k
Stephen F. Derose United States	24	349 1.6×	265 1.2×	448 2.7×	83 0.5×	186 1.5×	57	2.0k
Chuan‐Fen Liu United States	23	450 2.0×	784 3.6×	122 0.7×	281 1.8×	234 1.9×	77	1.8k
Elizabeth Cottrell United Kingdom	17	136 0.6×	386 1.8×	66 0.4×	234 1.5×	122 1.0×	70	1.0k
Seon‐Ha Kim South Korea	19	550 2.5×	335 1.5×	58 0.3×	149 1.0×	159 1.3×	57	1.5k
Mark Makowsky Canada	15	108 0.5×	321 1.5×	55 0.3×	140 0.9×	76 0.6×	37	952
Mohamed A. Osman Canada	13	101 0.5×	200 0.9×	541 3.3×	130 0.8×	94 0.8×	29	1.0k
Kinwah Fung Canada	26	181 0.8×	377 1.7×	89 0.5×	374 2.4×	327 2.7×	103	2.8k

Countries citing papers authored by Anna Kemp

Since Specialization

Citations

This map shows the geographic impact of Anna Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Kemp more than expected).

Fields of papers citing papers by Anna Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Kemp. The network helps show where Anna Kemp may publish in the future.

Co-authorship network of co-authors of Anna Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Kemp. A scholar is included among the top collaborators of Anna Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Kemp. Anna Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Michèle, Roger Hart, Elizabeth Milne, et al.. (2024). Ovulation induction and subfertile untreated conception groups offer improved options for interpreting risks associated with ART. Journal of Assisted Reproduction and Genetics. 41(4). 915–928.

Morrow, Richard L., Barbara Mintzes, Patrick C. Souverein, et al.. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety. 31(3). 179–190. 3 indexed citations

Kemp, Anna, Barbara Mintzes, Richard L. Morrow, et al.. (2022). Pioglitazone use in Australia and the United Kingdom following drug safety advisories on bladder cancer risk: An interrupted time series study. Pharmacoepidemiology and Drug Safety. 31(10). 1039–1045. 2 indexed citations

Choi, Stephanie, Duong Thuy Tran, Anna Kemp, et al.. (2021). The Comparative Effectiveness of Varenicline and Nicotine Patches for Smoking Abstinence During Pregnancy: Evidence From a Population-based Cohort Study. Nicotine & Tobacco Research. 23(10). 1664–1672. 7 indexed citations

Seaman, Karla, Max Bulsara, Frank Sanfilippo, et al.. (2021). Exploring the association between stroke and acute myocardial infarction and statins adherence following a medicines co-payment increase. Research in Social and Administrative Pharmacy. 17(10). 1780–1785. 2 indexed citations

Tran, Duong Thuy, David B. Preen, Kristjana Einarsdóttir, et al.. (2020). Use of smoking cessation pharmacotherapies during pregnancy is not associated with increased risk of adverse pregnancy outcomes: a population-based cohort study. BMC Medicine. 18(1). 15–15. 20 indexed citations

Pratt, Nicole, Mhairi Kerr, John D. Barratt, et al.. (2018). The validity of the Rx-Risk Comorbidity Index using medicines mapped to the Anatomical Therapeutic Chemical (ATC) Classification System. BMJ Open. 8(4). e021122–e021122. 199 indexed citations

Kemp, Anna, Nicole Pratt, Emmae Ramsay, & Elizabeth E. Roughead. (2018). Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use. Applied Health Economics and Health Policy. 17(3). 411–417. 4 indexed citations

Lopez, Derrick, Anna Kemp, Christobel Saunders, et al.. (2017). Clinical consultations and investigations before and after discontinuation of endocrine therapy in women with primary breast cancer. Public Health Research & Practice. 27(3). 1 indexed citations

10.

Seaman, Karla, Frank Sanfilippo, Elizabeth E. Roughead, et al.. (2017). Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia. BMJ Open. 7(6). e013691–e013691. 4 indexed citations

11.

Bremner, Alexandra, Louise M. Stewart, Anna Kemp, et al.. (2016). Declining rates of sterilization procedures in Western Australian women from 1990 to 2008: the relationship with age, hospital type, and government policy changes. Fertility and Sterility. 106(3). 704–709.e1. 1 indexed citations

12.

Kemp, Anna, Elizabeth E. Roughead, Christobel Saunders, et al.. (2016). Breast cancer recurrence following active treatment: determining its incidence in the NSW population. Public Health Research & Practice. 26(1). e2611607–e2611607. 5 indexed citations

13.

Malacova, Eva, et al.. (2014). Long-term risk of ectopic pregnancy varies by method of tubal sterilization: a whole-population study. Fertility and Sterility. 101(3). 728–734. 21 indexed citations

14.

Kemp, Anna, David B. Preen, Christobel Saunders, et al.. (2014). Early discontinuation of endocrine therapy for breast cancer: who is at risk in clinical practice?. SpringerPlus. 3(1). 282–282. 40 indexed citations

15.

Whyatt, David, Julie Marsh, Anna Kemp, et al.. (2014). The Ratchet Effect. Medical Care. 52(10). 901–908. 4 indexed citations

16.

Rogers, Kris, Anna Kemp, Andrew J. McLachlan, & Fiona Blyth. (2013). Adverse Selection? A Multi-Dimensional Profile of People Dispensed Opioid Analgesics for Persistent Non-Cancer Pain. PLoS ONE. 8(12). e80095–e80095. 41 indexed citations

17.

Kemp, Anna, J. Glover, David B. Preen, et al.. (2012). From the city to the bush: increases in patient co-payments for medicines have impacted on medicine use across Australia. Australian Health Review. 37(1). 4–10. 11 indexed citations

18.

Boudville, Neil, Anna Kemp, Philip A. Clayton, et al.. (2012). Recent Peritonitis Associates with Mortality among Patients Treated with Peritoneal Dialysis. Journal of the American Society of Nephrology. 23(8). 1398–1405. 179 indexed citations

19.

Kemp, Anna, David B. Preen, Frank Sanfilippo, et al.. (2011). Evaluating Pharmaceutical Policy Impacts Using Interrupted Time Series Analysis: An Australian Case Study. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 3(2). 229–241. 1 indexed citations

20.

Kemp, Anna. (2010). Consumer Co-payments for Medicines: Impact on Use and the Role of the Pharmacist. UWA Profiles and Research Repository (University of Western Australia). 29(9). 747–748. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact